Form 8-K - Current report:
SEC Accession No. 0000950170-25-099878
Filing Date
2025-07-30
Accepted
2025-07-30 07:05:29
Documents
12
Period of Report
2025-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrn-20250730.htm   iXBRL 8-K 57523
2 EX-99.1 amrn-ex99_1.htm EX-99.1 501625
3 GRAPHIC img114078973_0.jpg GRAPHIC 26945
  Complete submission text file 0000950170-25-099878.txt   741136

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20250730.xsd EX-101.SCH 32958
15 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20250730_htm.xml XML 4958
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 Ireland
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 Ireland 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 251163932
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)